Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ATDC Seed Capital Fund is a venture capital fund based in Atlanta, Georgia, managed by the Advanced Technology Development Center (ATDC) at Georgia Tech. It provides critical seed-stage and early-stage financing to technology-based startups that are members of the ATDC Signature program. The fund maintains a strong focus on the life sciences, including biotechnology, medical devices, and health informatics, as well as physical sciences and software. By investing in high-potential Georgia companies, the fund aims to stimulate economic growth and foster the commercialization of innovative technologies. It often co-invests with private venture capital firms and angel investors to provide the necessary capital for startups to reach significant milestones. The fund is a key component of Georgia's strategy to support its growing bioscience and technology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ATDC Seed Capital Fund.